HotHouse Therapeutics | $3,835,279 | (Dec 3, 2025)
minitap | $4,100,000 | (Dec 3, 2025)
Reema Health | $19,000,000 | (Dec 3, 2025)
Certified by Founder
Lodge
Mubadala Capital
investor
United Arab Emirates
- Abu Dhabi
- 09/11/2022
- Series B
- $70,000,000
Mubadala Capital is the wholly owned asset management arm of Mubadala Investment Company. Since its inception a decade ago, Mubadala Capital has grown to become a global asset manager of significant scale, with over US $16 billion of assets under management and a presence in London, New York, San Francisco, Rio de Janeiro, and headquarters in Abu Dhabi.
Through its four businesses, Mubadala Capital manages over US $11 billion in third-party capital vehicles on behalf of its institutional investors, including three private equity funds, two early stage venture funds, a public equities fund, and two funds in Brazil focused on special situations.
- Industry Venture Capital and Private Equity Principals
- Website https://www.mubadala.com/en/what-we-do/mubadala-capital
- LinkedIn https://www.linkedin.com/company/mubadala-capital/
Soxton.AI | $2,500,000 | (Dec 3, 2025)
Antares | $96,000,000 | (Dec 3, 2025)
Metri Bio | $5,000,000 | (Dec 3, 2025)
Quickture | $1,900,000 | (Dec 3, 2025)
Ripple Foods | $17,000,000 | (Dec 3, 2025)
LYRIC BIO | $6,600,000 | (Dec 3, 2025)
Ascentra | $2,000,000 | (Dec 3, 2025)
lizzyAI - AI interviews. Made human. | $5,000,000 | (Dec 3, 2025)
Trial Library | $10,000,000 | (Dec 3, 2025)